| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 1.3K | 9.1% |
| Total Income | 1.3K | 9.1% |
| Expenditure | 889.05 | 6.2% |
| PBT | 446.79 | 16.5% |
| Net Profit | 348.54 | 11.9% |
| OPM | 33.43% | 1.80pp |
| NPM | 26.10% | 0.67pp |
| EPS | 2.38 | 12.3% |
ResMed Announces Results of Operations for Quarter Ended September 30, 2025
04 May 2026 · 4 May, 8:24 am
Summary
ResMed Inc. announced the results of its operations for the quarter ended September 30, 2025, via a press release. The board of directors declared a quarterly cash dividend of US $0.60 per share, payable on December 18, 2025, to holders of record on November 13, 2025. Holders of CHESS Depositary Instruments trading on the Australian Securities Exchange will receive an equivalent amount in Australian currency.
Key Highlights
- 1
ResMed issued a press release describing the results of its operations for the quarter ended September 30, 2025.
- 2
A quarterly cash dividend of US $0.60 per share was declared by the board of directors.
- 3
The dividend record date is November 13, 2025, and payable on December 18, 2025.
- 4
Holders of CHESS Depositary Instruments will receive an equivalent amount in Australian currency.
Informational and educational content only. Not investment advice.